Približno 1 milijardo dolarjev … IBM pravi, da so sredstva Watson Health prinesla 230 milijonov dolarjev dobička pred obdavčitvijo

IBM je potrdil, da je zaslužil nekaj sto milijonov s prodajo zdravstvenih podatkov in analitičnih sredstev, ki jih hrani njegova enota Watson Health, v vrednosti 1 milijarde dolarjev.

Ko je bila tehnika bičali zasebnemu kapitalskemu podjetju Francisco Partners januarja naj bi bil ocenjen na a kul 1 milijarda dolarjev. V SEC 10-Q vložitev v ponedeljek je Big Blue razkril, da je dejansko prejel gotovinsko plačilo v višini 1,065 milijonov dolarjev.

However, during IBM’s latest zaslužek klic, je finančni direktor Jim Kavanaugh povedal analitikom Wall Streeta, da je prodaja, ki se je zaključila v drugem četrtletju, dosegla dobiček pred obdavčitvijo v višini približno četrtine glavne številke:

IBM didn’t realize the full benefit of the sale price because it had to account for expenses. “Mitigating that benefit to our overall profit results, we took charges to address stranded costs associated with the divestiture and absorbed operating losses related to the health business, together, [of] over $75 million,” he added.

Podjetje Watson Health je bilo ustanovljeno leta 2015, IBM pa je nato porabil približno 4 milijarde dolarjev za povezane prevzeme, da bi povečal prihodke in svoje tehnološke zmogljivosti, vendar se je dobiček izognil enoti.

Last month, Big Blue chairman and CEO Arvind Krishna confirmed he expunged Watson Health’s assets because his organization nisem imel potrebno vertikalno strokovno znanje, da lahko leti.

“It’s a question of verticals versus horizontals. We believe that we are better positioned to take these technologies. We will always have an industry lens but through our consulting team. We want to work on technologies that are horizontal across industries,” he told an audience at Bernstein’s 38th Annual Strategic Decisions Conference.

“Verticals should belong to people who really have all of the domain expertise, they have credibility in that vertical. And so I think that the healthcare companies, people in medical devices, they have the credibility to carry out how AI is applied to health in depth,” Krishna added.

Povedal je, da je prepričan, da bo umetna inteligenca, uporabljena v zdravstvu in drugih vertikalah, čez desetletje ali dve ogromen trg, zmagovalci pa bodo tisti z globokim strokovnim znanjem na tem področju.

Required will be doctors and nurses that talk to the buyers of Watson Health. “That’s not the IBM go-to-market field force, so there’s a misalignment.” ®

Opomba urednika: This article was updated to make clear that though IBM ultimately recorded just a $230 million pre-tax gain from the sale, it did receive a billion dollars in cash from private equity. We’re happy to clarify the situation.